Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Family Medicine | Gynecology | Internal Medicine | Oncology | Journal

Back to Journal Articles

Increased Risk of Cutaneous Melanoma in Cancer Survivors

Last Updated: December 21, 2011.

 

Highest risk seen for patients with previous diagnosis of cutaneous melanoma

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Patients with a previous diagnosis of cancer have an elevated risk of developing cutaneous melanoma, according to a study published in the December issue of the Archives of Dermatology.

WEDNESDAY, Dec. 21 (HealthDay News) -- Patients with a previous diagnosis of cancer have an elevated risk of developing cutaneous melanoma (CM), according to a study published in the December issue of the Archives of Dermatology.

Geoffrey B. Yang, from the Case Western Reserve School of Medicine in Cleveland, and colleagues investigated the risk of CM following a previous cancer. A total of 70,819 patients with CM as a first primary cancer, and 6,353 patients with CM following a previous cancer, were compared using data from the Surveillance, Epidemiology, and End Results database (1988 to 2007). The survival characteristics of the two groups were examined, and the relative risks (RRs) of developing CM following a previous cancer were calculated.

The investigators found that, for patients who were younger than 45 years when they were first diagnosed with cancer, there was a significantly elevated risk of CM following previous CM, other non-epithelial skin cancers, Kaposi sarcoma, female breast cancer, and lymphoma (RR, 11.89, 2.81, 3.26, 1.38, and 1.79, respectively). The risk of CM was significantly higher for patients aged 45 years or older at first cancer diagnosis, after a previous diagnosis of CM, other non-epithelial skin cancer, ocular melanoma, female breast cancer, prostate cancer, thyroid cancer, lymphoma, and leukemia (RR, 8.36, 2.00, 5.34, 1.12, 1.08, 1.40, 1.34, and 1.79, respectively). Age younger than 45 years at melanoma diagnosis, female gender, being married, being white versus black, decreasing Breslow depth, lack of tumor ulceration, no nodal involvement, and the absence of metastases were associated with better survival in both cohorts.

"Our findings revealed an increased risk of CM in cancer survivors compared with the general population," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: NCHS: Poisonings Are Leading Cause of Injury Deaths Next: Trauma Quality Indicators Linked to Clinical Outcomes

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.